‘Iron Deficiency Anemia Products Under Investigation and Market Review, H2 2015

Submitted by: Submitted by

Views: 10

Words: 542

Pages: 3

Category: Business and Industry

Date Submitted: 08/27/2015 04:54 AM

Report This Essay

Global Markets Direct's, ‘Iron Deficiency Anemia - Pipeline Review, H2 2015', provides an overview of the Iron Deficiency Anemia's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia and special features on late-stage and discontinued projects.

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=411469 . (This is a premium report price at US$2000 for a single user PDF license)

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope:

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Iron Deficiency Anemia and enlists all their major and minor projects

• The report summarizes all the dormant and discontinued pipeline projects

• A review of the Iron Deficiency Anemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

• A detailed assessment of monotherapy and combination therapy pipeline projects

• Coverage of the Iron Deficiency Anemia pipeline on the basis of target, MoA,...